NC
BCPC

nVerses Capital’s Balchem Corp BCPC Stock Holding History

nVerses Capital’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,522
Closed -$258K – 561
2026
Q1 		$258K Buy
+1,522
New +$258K 0.23% 200
2024
Q4 		– Sell
-200
Closed -$35.2K – 947
2024
Q3 		$35.2K Buy
+200
New +$34.1K 0.02% 715

Other funds holding BCPC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

nVerses Capital's BCPC Position: Q2 2026 in Review

nVerses Capital sold out of Balchem Corp (BCPC) in Q2 2026, closing a stake of 1,522 shares — an estimated $258K sold.

nVerses Capital first reported a position in BCPC in Q3 2024 and held it in 2 quarters. The position peaked at $258K in Q1 2026. 329 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

  • nVerses Capital reported no remaining Balchem Corp position as of Q2 2026 after selling out during the quarter.
  • nVerses Capital sold 1,522 Balchem Corp shares in Q2 2026, an estimated $258K.
  • nVerses Capital first reported a position in Balchem Corp in Q3 2024 and held it in 2 quarters.
  • nVerses Capital's Balchem Corp position peaked at $258K in Q1 2026.
  • 329 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.